"Countries of Middle Europe, Germany, Austria and Switzerland are markets for which CreAgri has much hope," said Roberto Crea, Ph.D., inventor of Hidrox, and founder and CEO of California based CreAgri, Inc. "Eurochem Feinchemie will be soon marketing the healing power of the "all natural," solvent-free formulation of hydroxytyrosol to the region's dietary, skincare, food and beverages industries. Hidrox will provide its users with the opportunity to leverage upon the broad anti-inflammatory, antioxidant and immune-modulating activities of Hidrox for the management of health conditions affecting joints, skin and cardiovascular system and to sustain the body's innate immune response to environmental insults."
The multi-year agreement, which includes joint research and development, contemplates also the creation of new products to be introduced in Europe.
"We are extremely excited about the excellent prospects of Hidrox in our markets," said Oliver Schulz, B.Sc., founder and scientific director of Eurochem. "It is very rare for us to take on innovative materials that have such a well-documented scientific base. The cooperation with CreAgri, Inc. for Hidrox comes at the perfect time when the significance of the benefits of the Mediterranean diet and its emphasis on inflammation control of its components has been widely recognized. And Hidrox is in our belief the core of the success of the Med diet!"